市場調査レポート
商品コード
1368146

ペンニードル市場:タイプ別、長さ別、用途別、設置場所別、購入形態別、地域別 - 2028年までの予測

Pen Needles Market by Type (Standard Pen & Safety Pen Needles), Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP 1, Growth Hormone), and Mode of Purchase, End User, Unmet Needs, Key Stakeholders, Buying Criteria - Global Forecast to 2028

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 249 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.11円
ペンニードル市場:タイプ別、長さ別、用途別、設置場所別、購入形態別、地域別 - 2028年までの予測
出版日: 2023年10月16日
発行: MarketsandMarkets
ページ情報: 英文 249 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界のペンニードルの市場規模は、2023年の16億米ドルから2028年には25億米ドルに達し、予測期間中のCAGRは9.1%と予測されています。

レポート範囲
対象期間2021-2028
基準年2022
予測期間2023-2028
単位金額 (USD) Billion
セグメントタイプ別、長さ別、用途別、設置場所別、購入形態別、地域別
対象地域欧州、北米、ラテンアメリカ、アジア太平洋、中東アフリカ

バイオシミラー医薬品への嗜好の高まり、在宅治療へのシフトの増加、ペン型注射器の安全性に関する義務化は、市場の主要参入企業に幅広い成長機会を提供しています。しかし、ドラッグデリバリーの代替手段への嗜好、新興諸国における不十分な償還、注射針への不安が市場の成長を抑制しています。

購入形態別では、2022年の市場シェアは市販用が最も大きくなりました。店頭購入には、薬局、医療用品販売業者/供給業者などの店舗からの購入が含まれます。薬局による製品の現地配送、薬局、供給業者、販売業者による割引の提供などが、この市場の成長を促進する要因となっています。

2022年のペンニードル市場では、在宅ケア分野が最大のシェアを占めました。また、同セグメントは予測期間中に最も高いCAGRで成長する見込みです。インスリンペン型注射器やペン型注射器メーカーが提供する患者トレーニング、家庭用ペン型注射器の採用増加などは、今後数年間の同セグメントの成長を支える要因の一部です。

2022年のペンニードル市場では、8mmセグメントが最大のシェアを占めましたが、予測期間中は4mmセグメントが最も急成長するセグメントとなりそうです。4mm針の急成長は、針の長さの中で最も痛みが少ないことに起因しています。さらに、インスリン投与の効率も高くなります。

様々な薬物投与方法に対する意識の高まり、ペン型注射器の採用の増加、ヘルスケア支出の増加、可処分所得の増加、糖尿病有病率の増加は、アジア太平洋におけるペン型注射器市場の成長の主な要因の一部です。

当レポートでは、世界のペンニードル市場について調査し、タイプ別、長さ別、用途別、設置場所別、購入形態別、地域別動向、および市場に参入する企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場力学
  • 償還シナリオ
  • 価格分析
  • バリューチェーン分析
  • 生態系/市場マップ
  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 規制分析
  • HSコード:ペンインジェクター
  • 特許分析
  • 主要な利害関係者と購入基準
  • ケーススタディ分析
  • 技術分析
  • 主要な会議とイベント
  • 隣接市場分析
  • ペンニードル市場におけるユーザー要件

第6章 ペンニードル市場、タイプ別

  • イントロダクション
  • 標準ペンニードル
  • 安全ペンニードル

第7章 ペンニードル市場、長さ別

  • イントロダクション
  • 8mm
  • 5mm
  • 6mm
  • 4mm
  • 12mm
  • 10mm

第8章 ペンニードル市場、用途別

  • イントロダクション
  • インスリン療法
  • グルカゴン様ペプチド-1療法(GLP-1療法)
  • 成長ホルモン療法
  • 骨粗鬆症
  • その他

第9章 ペンニードル市場、設置場所別

  • イントロダクション
  • 在宅ケア
  • 病院と診療所
  • その他

第10章 ペンニードル市場、購入形態別

  • イントロダクション
  • 処方箋による購入
  • 店頭購入
  • オンライン購入
  • その他

第11章 ペンニードル市場、地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第12章 競合情勢

  • 概要
  • 主要参入企業の戦略
  • 収益シェア分析
  • 市場シェア分析
  • 企業評価マトリックス(2022年)
  • 新興企業/中小企業の評価マトリックス(2022年)
  • 競争シナリオと動向

第13章 企業プロファイル

  • 主要参入企業
    • EMBECTA CORP.(PART OF BD)
    • NOVO NORDISK A/S
    • YPSOMED AG
    • B. BRAUN MELSUNGEN AG
    • TERUMO CORPORATION
    • NIPRO CORPORATION
    • OWEN MUMFORD
    • ARKRAY, INC.
    • ULTIMED, INC.
    • HINDUSTAN SYRINGES & MEDICAL DEVICES LTD.
    • MONTMED, INC.
    • HTL-STREFA
    • ALLISON MEDICAL, INC.
    • GLUCORX LIMITED
    • BERPU MEDICAL TECHNOLOGY CO., LTD.
    • ADVACARE PHARMA
    • ARTSANA GROUP
    • PROMISEMED MEDICAL DEVICES INC.
    • TRIVIDIA HEALTH, INC.
    • VOGT MEDICAL VERTRIEB GMBH
  • その他の企業
    • VAN HEEK MEDICAL
    • SIMPLE DIAGNOSTICS
    • IYON MEDICAL
    • LINKS MEDICAL PRODUCTS, INC.
    • MHC MEDICAL PRODUCTS, LLC

第14章 付録

目次
Product Code: MD 2851

"The global pen needles market size is projected to reach USD 2.5 billion by 2028 from USD 1.6 billion in 2023, at a CAGR of 9.1% during the forecast period".

Scope of the Report
Years Considered for the Study2021-2028
Base Year2022
Forecast Period2023-2028
Units ConsideredValue (USD) Billion
SegmentsApplication, Type, Setting, Mode of Purchase, Region, and Length
Regions coveredEurope, North America, LATAM, APAC, and MEA

The growing preference for biosimilar drugs, increasing shift of therapy to home settings, and mandates pertaining to safety pen needles provide a wide range of growth opportunities for key players in the market. However, the preference for alternative modes of drug delivery, poor reimbursement in developing countries, and needle anxiety restrain the market growth.

"The over the counter segment captured the largest share in pen needles market, by mode of purchase, in 2022."

Based on the mode of purchase, the pen needles market is segmented into prescription-based, over the counter, online purchase, and other modes of purchase. The over-the-counter segment accounted for the largest market share in 2022. Over the counter purchase includes all purchases made from stores such as pharmacies, medical supplies distributors/suppliers, etc. Local delivery of products by pharmacies, and discounts provided by pharmacies, suppliers and distributors are some factors driving the growth of this market.

"The homecare segment to witness highest growth rate in pen needles market, by setting during the forecast period."

Based on the setting, the pen needles market is segmented into homes, hospitals & clinics, and other settings. The home care segment occupied th largest share of the pen needles market in 2022. The segment was also expected to grow with the highest CAGR during the forecast period. The patient training provided by insulin pen injectors and pen needle manufacturers, and the increasing adoption of pen injectors for home use are some of the factors which supports the growth of the segment in the coming years.

"The 4mm segment is expected to be the fastest growing segment of the pen needles market, by length, during the forecast period"

The 8mm segment accounted for the largest share of the pen needles market in 2022, while the 4mm segment is likely to be the fastest growing segment during the forecast period. The rapid growth of the 4mm needles can be attributed to the fact that they cause the least pain of all needle lengths. Additionally, they also have a a high efficiency of insulin administration.

"The Asia Pacific market to grow at the highest CAGR during the forecast period."

The pen needles market is segmented into five major regions, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The increase in the awareness of various modes of drug administration, increasing adoption of pen injectors, increasing healthcare expenditures, rising of the disposable incomes, and increasing prevalence of diabetes are some of the key factors in growth of the pen needles market in Asia Pacific region.

Breakdown of supply-side primary interviews:

  • By Company Type: Tier 1: 22%, Tier 2: 36%, and Tier 3: 42%
  • By Designation: C-level: 23%, D-level: 28%, and Others: 49%
  • By Region: North America: 40%, Europe: 31%, APAC: 25%, Latin America: 6%, and the Middle East & Africa: 4%

The major players operating in the pen needles market are Novo Nordisk (Denmark), Embecta Corp. (US), Ypsomed Holding AG (Switzerland), and B. Braun Melsungen AG (Germany).

Research Coverage

This report studies the pen needles market based on the region, type, length, mode of purchase, setting, and application. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Key Benefits of Buying the Report

The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one, or a combination of the below-mentioned five strategies.

.

This report provides insights into the following pointers:

.

  • Market Driver: The growth of the market attributes to increase of prevalence of diabetes globally and increasing adoption of pen injectors, especially in developed countries.
  • Market Penetration: Comprehensive information on the product portfolios of the top players in the pen needles market. The report analyzes the market based on the setting, region, type, mode of purchase, application, and length.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the pen needles market.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for pen needles across regions.
  • Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the pen needles market.
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the pen needles market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
    • 1.2.2 MARKET SEGMENTATION
    • 1.2.3 YEARS CONSIDERED
  • 1.3 CURRENCY CONSIDERED
    • TABLE 1 STANDARD CURRENCY CONVERSION RATES
  • 1.4 LIMITATIONS
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES
  • 1.7 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 PRIMARY SOURCES
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY SETTING AND REGION
    • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 6 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
    • FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION: EMBECTA CORP. (2022)
    • FIGURE 8 REVENUE ANALYSIS OF TOP FIVE COMPANIES: PEN NEEDLES MARKET (2022)
    • FIGURE 9 DEMAND-SIDE ANALYSIS
    • FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023-2028)
    • FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • FIGURE 12 TOP-DOWN APPROACH
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 13 DATA TRIANGULATION METHODOLOGY
  • 2.4 MARKET SHARE ANALYSIS
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 RISK ASSESSMENT
    • TABLE 2 RISK ASSESSMENT ANALYSIS
  • 2.7 METHODOLOGY-RELATED LIMITATIONS
  • 2.8 RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY

    • FIGURE 14 PEN NEEDLES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 15 PEN NEEDLES MARKET, BY LENGTH, 2023 VS. 2028 (USD MILLION)
    • FIGURE 16 PEN NEEDLES MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    • FIGURE 17 PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 18 PEN NEEDLES MARKET, BY SETTING, 2023 VS. 2028 (USD MILLION)
    • FIGURE 19 GEOGRAPHIC GROWTH OPPORTUNITIES

4 PREMIUM INSIGHTS

  • 4.1 PEN NEEDLES MARKET OVERVIEW
    • FIGURE 20 RISING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET GROWTH DURING FORECAST PERIOD
  • 4.2 ASIA PACIFIC: PEN NEEDLES MARKET, BY LENGTH (2023)
    • FIGURE 21 5MM SEGMENT TO DOMINATE ASIA PACIFIC MARKET
  • 4.3 GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 22 EMERGING MARKETS TO GROW AT HIGHER CAGR DURING FORECAST PERIOD
  • 4.4 REGIONAL MIX
    • FIGURE 23 NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2022

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 24 PEN NEEDLES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising incidence of chronic diseases
    • FIGURE 25 NUMBER OF PEOPLE WITH CHRONIC CONDITIONS IN US, 1995-2030 (MILLION INDIVIDUALS)
    • FIGURE 26 TYPE 1 DIABETIC POPULATION, BY COUNTRY (2022)
      • 5.2.1.2 Favorable reimbursements in mature markets
      • 5.2.1.3 Growing adoption of self-administration
      • 5.2.1.4 Decreasing prices of insulin formulations
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Alternative methods of drug delivery
      • 5.2.2.2 Poor reimbursements in emerging markets
      • 5.2.2.3 Needle anxiety
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growing preference for biosimilar drugs
      • 5.2.3.2 High-growth potential of emerging economies
      • 5.2.3.3 Rising healthcare expenditure on diabetes
      • 5.2.3.4 Regulatory mandates for safety pen needles
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Reuse of pen needles
      • 5.2.4.2 Misuse of injection pens
  • 5.3 REIMBURSEMENT SCENARIO
    • TABLE 3 REIMBURSEMENT OF PEN NEEDLES, BY COUNTRY
  • 5.4 PRICING ANALYSIS
    • 5.4.1 AVERAGE SELLING PRICE FOR PEN NEEDLES, BY TYPE
    • TABLE 4 PRICING OF PEN NEEDLES, BY KEY PLAYERS
    • FIGURE 27 AVERAGE SELLING PRICE OF PEN NEEDLES, BY TYPE
    • 5.4.2 AVERAGE SELLING PRICE TRENDS
  • 5.5 VALUE CHAIN ANALYSIS
    • FIGURE 28 PEN NEEDLES MARKET: VALUE CHAIN ANALYSIS
  • 5.6 ECOSYSTEM/MARKET MAP
    • FIGURE 29 PEN NEEDLES MARKET: ECOSYSTEM/MARKET MAP
  • 5.7 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 5 PEN NEEDLES MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.7.1 INTENSITY OF COMPETITIVE RIVALRY
    • 5.7.2 BARGAINING POWER OF SUPPLIERS
    • 5.7.3 BARGAINING POWER OF BUYERS
    • 5.7.4 THREAT OF SUBSTITUTES
    • 5.7.5 THREAT OF NEW ENTRANTS
  • 5.8 SUPPLY CHAIN ANALYSIS
    • FIGURE 30 PEN NEEDLES MARKET: SUPPLY CHAIN ANALYSIS
  • 5.9 REGULATORY ANALYSIS
    • 5.9.1 NORTH AMERICA
      • 5.9.1.1 US
    • TABLE 6 US FDA: MEDICAL DEVICE CLASSIFICATION
    • TABLE 7 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
      • 5.9.1.2 Canada
    • TABLE 8 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
    • FIGURE 31 CANADA: CLASS II MEDICAL DEVICE APPROVAL PROCESS
    • 5.9.2 EUROPE
    • FIGURE 32 EUROPE: CE APPROVAL PROCESS FOR CLASS IIA MEDICAL DEVICES
    • 5.9.3 ASIA PACIFIC
      • 5.9.3.1 Japan
    • TABLE 9 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
      • 5.9.3.2 China
    • TABLE 10 CHINA: REGULATORY BODIES APPOINTED FOR MEDICAL DEVICE APPROVAL
    • TABLE 11 CHINA: CLASSIFICATION OF MEDICAL DEVICES
      • 5.9.3.3 India
    • 5.9.4 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 12 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 13 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 14 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 15 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.10 HS CODES: PEN INJECTORS
  • 5.11 PATENT ANALYSIS
    • 5.11.1 PATENT PUBLICATION TRENDS FOR PEN NEEDLES
    • FIGURE 33 PATENT PUBLICATION TRENDS (JANUARY 2013-SEPTEMBER 2023)
    • 5.11.2 INSIGHTS: JURISDICTION AND TOP APPLICANTS ANALYSIS
    • FIGURE 34 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR PEN NEEDLE PATENTS (JANUARY 2013-SEPTEMBER 2023)
    • FIGURE 35 TOP APPLICANT COUNTRIES FOR PEN NEEDLE PATENTS (JANUARY 2013- SEPTEMBER 2023)
    • TABLE 16 PEN INJECTORS MARKET: MAJOR PATENTS
  • 5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 36 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PEN NEEDLES
    • TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PEN NEEDLES
    • 5.12.2 BUYING CRITERIA
    • FIGURE 37 KEY BUYING CRITERIA FOR PEN NEEDLES, BY TYPE
    • TABLE 18 KEY BUYING CRITERIA FOR PEN NEEDLES
  • 5.13 CASE STUDY ANALYSIS
    • TABLE 19 CONTRIBUTION OF SMART INSULIN PENS FOR DIABETES MANAGEMENT
  • 5.14 TECHNOLOGY ANALYSIS
    • 5.14.1 KEY TECHNOLOGY
      • 5.14.1.1 Fluid flow enhancement technology
    • 5.14.2 COMPLEMENTARY TECHNOLOGY
      • 5.14.2.1 Microfabricated needles
      • 5.14.2.2 AI in pen injectors
    • 5.14.3 ADJACENT TECHNOLOGY
      • 5.14.3.1 Autoinjectors
  • 5.15 KEY CONFERENCES AND EVENTS
    • TABLE 20 PEN NEEDLES MARKET: DETAILED LIST OF CONFERENCES AND EVENTS (2023-2024)
  • 5.16 ADJACENT MARKETS ANALYSIS
    • FIGURE 38 PEN NEEDLES MARKET: ADJACENT MARKETS
  • 5.17 USER REQUIREMENTS IN PEN NEEDLES MARKET

6 PEN NEEDLES MARKET, BY TYPE

  • 6.1 INTRODUCTION
    • TABLE 21 PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 22 PEN NEEDLES MARKET, BY REGION, 2021-2028 (MILLION UNITS)
  • 6.2 STANDARD PEN NEEDLES
    • 6.2.1 GROWING PREFERENCE DUE TO LOW COSTS TO DRIVE MARKET
    • TABLE 23 STANDARD PEN NEEDLES OFFERED BY KEY PLAYERS
    • TABLE 24 STANDARD PEN NEEDLES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 25 STANDARD PEN NEEDLES MARKET, BY REGION, 2021-2028 (MILLION UNITS)
  • 6.3 SAFETY PEN NEEDLES
    • 6.3.1 CONCERNS ASSOCIATED WITH NEEDLESTICK INJURIES TO PROPEL MARKET
    • TABLE 26 SAFETY PEN NEEDLES OFFERED BY KEY PLAYERS
    • TABLE 27 SAFETY PEN NEEDLES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 28 SAFETY PEN NEEDLES MARKET, BY REGION, 2021-2028 (MILLION UNITS)

7 PEN NEEDLES MARKET, BY LENGTH

  • 7.1 INTRODUCTION
    • TABLE 29 PEN NEEDLES MARKET, BY LENGTH, 2021-2028 (USD MILLION)
  • 7.2 8MM
    • 7.2.1 WIDE ADOPTION IN NORTH AMERICA TO BOOST DEMAND
    • TABLE 30 8MM PEN NEEDLES OFFERED BY KEY PLAYERS
    • TABLE 31 8MM PEN NEEDLES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.3 5MM
    • 7.3.1 SHORTER LENGTH TO FUEL UPTAKE
    • TABLE 32 5MM PEN NEEDLES OFFERED BY KEY PLAYERS
    • TABLE 33 5MM PEN NEEDLES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.4 6MM
    • 7.4.1 FAVORABLE REIMBURSEMENTS TO BOOST DEMAND
    • TABLE 34 6MM PEN NEEDLES OFFERED BY KEY PLAYERS
    • TABLE 35 6MM PEN NEEDLES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.5 4MM
    • 7.5.1 WIDE ADOPTION AMONG CHILDREN FOR INSULIN DELIVERY TO DRIVE DEMAND
    • TABLE 36 4MM PEN NEEDLES OFFERED BY KEY PLAYERS
    • TABLE 37 4MM PEN NEEDLES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.6 12MM
    • 7.6.1 HIGH UTILIZATION OF SHORTER NEEDLES TO LIMIT ADOPTION
    • TABLE 38 12MM PEN NEEDLES OFFERED BY KEY PLAYERS
    • TABLE 39 12MM PEN NEEDLES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.7 10MM
    • 7.7.1 PAINFUL ADMINISTRATION TO RESTRAIN ADOPTION
    • TABLE 40 10MM PEN NEEDLES OFFERED BY KEY PLAYERS
    • TABLE 41 10MM PEN NEEDLES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)

8 PEN NEEDLES MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 42 PEN NEEDLES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 8.2 INSULIN THERAPY
    • 8.2.1 RISING INCIDENCE OF DIABETES TO PROPEL MARKET
    • TABLE 43 PEN NEEDLES MARKET FOR INSULIN THERAPY, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.3 GLUCAGON-LIKE PEPTIDE-1 THERAPY (GLP-1 THERAPY)
    • 8.3.1 GROWING FOCUS OF PHARMA COMPANIES ON GLP-1-BASED THERAPIES TO DRIVE MARKET
    • TABLE 44 PEN NEEDLES MARKET FOR GLP-1 THERAPY, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.4 GROWTH HORMONE THERAPY
    • 8.4.1 RECURRING REQUIREMENT OF INJECTIONS TO RESTRAIN MARKET
    • TABLE 45 PEN NEEDLES MARKET FOR GROWTH HORMONE THERAPY, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.5 OSTEOPOROSIS
    • 8.5.1 RISING VITAMIN D DEFICIENCY CASES TO PROPEL MARKET
    • TABLE 46 PEN NEEDLES MARKET FOR OSTEOPOROSIS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.6 OTHER APPLICATIONS
    • TABLE 47 PEN NEEDLES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)

9 PEN NEEDLES MARKET, BY SETTING

  • 9.1 INTRODUCTION
    • TABLE 48 PEN NEEDLES MARKET, BY SETTING, 2021-2028 (USD MILLION)
  • 9.2 HOME CARE SETTINGS
    • 9.2.1 GROWING PREFERENCE FOR SELF-ADMINISTRATION OF INSULIN TO PROPEL MARKET
    • TABLE 49 PEN NEEDLES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.3 HOSPITALS AND CLINICS
    • 9.3.1 INCREASING ADOPTION OF SAFETY PEN NEEDLES TO DRIVE MARKET
    • TABLE 50 PEN NEEDLES MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.4 OTHER SETTINGS
    • TABLE 51 PEN NEEDLES MARKET FOR OTHER SETTINGS, BY COUNTRY, 2021-2028 (USD MILLION)

10 PEN NEEDLES MARKET, BY MODE OF PURCHASE

  • 10.1 INTRODUCTION
    • TABLE 52 PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021-2028 (USD MILLION)
  • 10.2 PRESCRIPTION-BASED PURCHASE
    • 10.2.1 RETAIL PURCHASES TO SUPPORT MARKET GROWTH
    • TABLE 53 PEN NEEDLES MARKET FOR PRESCRIPTION-BASED PURCHASE, BY COUNTRY, 2021-2028 (USD MILLION)
  • 10.3 OVER-THE-COUNTER PURCHASE
    • 10.3.1 DISCOUNTS OFFERED BY LOCAL PHARMACIES, SUPPLIERS, AND DISTRIBUTORS TO DRIVE MARKET
    • TABLE 54 PEN NEEDLES MARKET FOR OVER-THE-COUNTER PURCHASE, BY COUNTRY, 2021-2028 (USD MILLION)
  • 10.4 ONLINE PURCHASE
    • 10.4.1 CONVENIENT TIME-EFFICIENT BENEFITS TO PROPEL MARKET
    • TABLE 55 PEN NEEDLES MARKET FOR ONLINE PURCHASES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 10.5 OTHER MODES OF PURCHASE
    • TABLE 56 PEN NEEDLES MARKET FOR OTHER MODES OF PURCHASE, BY COUNTRY, 2021-2028 (USD MILLION)

11 PEN NEEDLES MARKET, BY REGION

  • 11.1 INTRODUCTION
    • TABLE 57 PEN NEEDLES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • FIGURE 39 EMERGING MARKETS TO GROW AT HIGHER GROWTH RATE DURING FORECAST PERIOD
  • 11.2 NORTH AMERICA
    • FIGURE 40 NORTH AMERICA: PEN NEEDLES MARKET SNAPSHOT
    • TABLE 58 NORTH AMERICA: PEN NEEDLES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 59 NORTH AMERICA: PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 60 NORTH AMERICA: PEN NEEDLES MARKET, BY LENGTH, 2021-2028 (USD MILLION)
    • TABLE 61 NORTH AMERICA: PEN NEEDLES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 62 NORTH AMERICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021-2028 (USD MILLION)
    • TABLE 63 NORTH AMERICA: PEN NEEDLES MARKET, BY SETTING, 2021-2028 (USD MILLION)
    • 11.2.1 US
      • 11.2.1.1 Favorable reimbursements to propel market
    • FIGURE 41 TOTAL FERTILITY RATE IN US POPULATION (1990-2021)
    • TABLE 64 US: MACROECONOMIC INDICATORS
    • TABLE 65 US: PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 66 US: PEN NEEDLES MARKET, BY LENGTH, 2021-2028 (USD MILLION)
    • TABLE 67 US: PEN NEEDLES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 68 US: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021-2028 (USD MILLION)
    • TABLE 69 US: PEN NEEDLES MARKET, BY SETTING, 2021-2028 (USD MILLION)
    • 11.2.2 CANADA
      • 11.2.2.1 Rising prevalence of diabetes to drive market
    • TABLE 70 CANADA: MACROECONOMIC INDICATORS
    • TABLE 71 CANADA: PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 72 CANADA: PEN NEEDLES MARKET, BY LENGTH, 2021-2028 (USD MILLION)
    • TABLE 73 CANADA: PEN NEEDLES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 74 CANADA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021-2028 (USD MILLION)
    • TABLE 75 CANADA: PEN NEEDLES MARKET, BY SETTING, 2021-2028 (USD MILLION)
    • 11.2.3 NORTH AMERICA: RECESSION IMPACT
  • 11.3 EUROPE
    • TABLE 76 EUROPE: PEN NEEDLES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 77 EUROPE: PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 78 EUROPE: PEN NEEDLES MARKET, BY LENGTH, 2021-2028 (USD MILLION)
    • TABLE 79 EUROPE: PEN NEEDLES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 80 EUROPE: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021-2028 (USD MILLION)
    • TABLE 81 EUROPE: PEN NEEDLES MARKET, BY SETTING, 2021-2028 (USD MILLION)
    • 11.3.1 GERMANY
      • 11.3.1.1 High healthcare spending to propel market
    • TABLE 82 GERMANY: MACROECONOMIC INDICATORS
    • TABLE 83 GERMANY: PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 84 GERMANY: PEN NEEDLES MARKET, BY LENGTH, 2021-2028 (USD MILLION)
    • TABLE 85 GERMANY: PEN NEEDLES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 86 GERMANY: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021-2028 (USD MILLION)
    • TABLE 87 GERMANY: PEN NEEDLES MARKET, BY SETTING, 2021-2028 (USD MILLION)
    • 11.3.2 UK
      • 11.3.2.1 NHS support and growing access to cost-effective pen needles to drive market
    • TABLE 88 UK: MACROECONOMIC INDICATORS
    • TABLE 89 UK: PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 90 UK: PEN NEEDLES MARKET, BY LENGTH, 2021-2028 (USD MILLION)
    • TABLE 91 UK: PEN NEEDLES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 92 UK: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021-2028 (USD MILLION)
    • TABLE 93 UK: PEN NEEDLES MARKET, BY SETTING, 2021-2028 (USD MILLION)
    • 11.3.3 FRANCE
      • 11.3.3.1 Favorable health insurance system to propel market
    • TABLE 94 FRANCE: MACROECONOMIC INDICATORS
    • TABLE 95 FRANCE: PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 96 FRANCE: PEN NEEDLES MARKET, BY LENGTH, 2021-2028 (USD MILLION)
    • TABLE 97 FRANCE: PEN NEEDLES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 98 FRANCE: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021-2028 (USD MILLION)
    • TABLE 99 FRANCE: PEN NEEDLES MARKET, BY SETTING, 2021-2028 (USD MILLION)
    • 11.3.4 ITALY
      • 11.3.4.1 Low product pricing to support market growth
    • TABLE 100 ITALY: MACROECONOMIC INDICATORS
    • TABLE 101 ITALY: PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 102 ITALY: PEN NEEDLES MARKET, BY LENGTH, 2021-2028 (USD MILLION)
    • TABLE 103 ITALY: PEN NEEDLES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 104 ITALY: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021-2028 (USD MILLION)
    • TABLE 105 ITALY: PEN NEEDLES MARKET, BY SETTING, 2021-2028 (USD MILLION)
    • 11.3.5 SPAIN
      • 11.3.5.1 Supportive regulations mandating the use of safety pen needles to propel market
    • TABLE 106 SPAIN: MACROECONOMIC INDICATORS
    • TABLE 107 SPAIN: PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 108 SPAIN: PEN NEEDLES MARKET, BY LENGTH, 2021-2028 (USD MILLION)
    • TABLE 109 SPAIN: PEN NEEDLES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 110 SPAIN: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021-2028 (USD MILLION)
    • TABLE 111 SPAIN: PEN NEEDLES MARKET, BY SETTING, 2021-2028 (USD MILLION)
    • 11.3.6 REST OF EUROPE
    • TABLE 112 REST OF EUROPE: PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 113 REST OF EUROPE: PEN NEEDLES MARKET, BY LENGTH, 2021-2028 (USD MILLION)
    • TABLE 114 REST OF EUROPE: PEN NEEDLES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 115 REST OF EUROPE: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021-2028 (USD MILLION)
    • TABLE 116 REST OF EUROPE: PEN NEEDLES MARKET, BY SETTING, 2021-2028 (USD MILLION)
    • 11.3.7 EUROPE: RECESSION IMPACT
  • 11.4 ASIA PACIFIC
    • FIGURE 42 ASIA PACIFIC: PEN NEEDLES MARKET SNAPSHOT
    • TABLE 117 ASIA PACIFIC: PEN NEEDLES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 118 ASIA PACIFIC: PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 119 ASIA PACIFIC: PEN NEEDLES MARKET, BY LENGTH, 2021-2028 (USD MILLION)
    • TABLE 120 ASIA PACIFIC: PEN NEEDLES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 121 ASIA PACIFIC: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021-2028 (USD MILLION)
    • TABLE 122 ASIA PACIFIC: PEN NEEDLES MARKET, BY SETTING, 2021-2028 (USD MILLION)
    • 11.4.1 JAPAN
      • 11.4.1.1 Supportive reimbursement policies and universal healthcare coverage to propel market
    • TABLE 123 JAPAN: MACROECONOMIC INDICATORS
    • TABLE 124 JAPAN: PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 125 JAPAN: PEN NEEDLES MARKET, BY LENGTH, 2021-2028 (USD MILLION)
    • TABLE 126 JAPAN: PEN NEEDLES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 127 JAPAN: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021-2028 (USD MILLION)
    • TABLE 128 JAPAN: PEN NEEDLES MARKET, BY SETTING, 2021-2028 (USD MILLION)
    • 11.4.2 CHINA
      • 11.4.2.1 Large patient population and healthcare infrastructure improvements to drive market growth
    • TABLE 129 CHINA: MACROECONOMIC INDICATORS
    • TABLE 130 CHINA: PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 131 CHINA: PEN NEEDLES MARKET, BY LENGTH, 2021-2028 (USD MILLION)
    • TABLE 132 CHINA: PEN NEEDLES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 133 CHINA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021-2028 (USD MILLION)
    • TABLE 134 CHINA: PEN NEEDLES MARKET, BY SETTING, 2021-2028 (USD MILLION)
    • 11.4.3 AUSTRALIA & NEW ZEALAND
      • 11.4.3.1 High healthcare expenditure to support market growth
    • TABLE 135 AUSTRALIA & NEW ZEALAND: PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 136 AUSTRALIA & NEW ZEALAND: PEN NEEDLES MARKET, BY LENGTH, 2021-2028 (USD MILLION)
    • TABLE 137 AUSTRALIA & NEW ZEALAND: PEN NEEDLES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 138 AUSTRALIA & NEW ZEALAND: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021-2028 (USD MILLION)
    • TABLE 139 AUSTRALIA & NEW ZEALAND: PEN NEEDLES MARKET, BY SETTING, 2021-2028 (USD MILLION)
    • 11.4.4 INDIA
      • 11.4.4.1 Healthcare infrastructural improvements and rising disease burden to propel market
    • TABLE 140 INDIA: MACROECONOMIC INDICATORS
    • TABLE 141 INDIA: PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 142 INDIA: PEN NEEDLES MARKET, BY LENGTH, 2021-2028 (USD MILLION)
    • TABLE 143 INDIA: PEN NEEDLES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 144 INDIA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021-2028 (USD MILLION)
    • TABLE 145 INDIA: PEN NEEDLES MARKET, BY SETTING, 2021-2028 (USD MILLION)
    • 11.4.5 SOUTH KOREA
      • 11.4.5.1 Rising incidence of obesity and hypertension to support market growth
    • TABLE 146 SOUTH KOREA: MACROECONOMIC INDICATORS
    • TABLE 147 SOUTH KOREA: PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 148 SOUTH KOREA: PEN NEEDLES MARKET, BY LENGTH, 2021-2028 (USD MILLION)
    • TABLE 149 SOUTH KOREA: PEN NEEDLES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 150 SOUTH KOREA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021-2028 (USD MILLION)
    • TABLE 151 SOUTH KOREA: PEN NEEDLES MARKET, BY SETTING, 2021-2028 (USD MILLION)
    • 11.4.6 SOUTHEAST ASIA
      • 11.4.6.1 Growing awareness about diabetes to propel market
    • FIGURE 43 PREVALENCE OF DIABETES IN SOUTHEAST ASIA (2021 VS. 2030)
    • FIGURE 44 HEALTHCARE EXPENDITURE (% GDP) IN SOUTHEAST ASIA (2020)
    • FIGURE 45 ELDERLY POPULATION IN SOUTHEAST ASIA (2022)
    • TABLE 152 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 153 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY LENGTH, 2021-2028 (USD MILLION)
    • TABLE 154 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 155 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021-2028 (USD MILLION)
    • TABLE 156 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY SETTING, 2021-2028 (USD MILLION)
    • 11.4.7 REST OF ASIA PACIFIC
    • TABLE 157 REST OF ASIA PACIFIC: PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 158 REST OF ASIA PACIFIC: PEN NEEDLES MARKET, BY LENGTH, 2021-2028 (USD MILLION)
    • TABLE 159 REST OF ASIA PACIFIC: PEN NEEDLES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 160 REST OF ASIA PACIFIC: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021-2028 (USD MILLION)
    • TABLE 161 REST OF ASIA PACIFIC: PEN NEEDLES MARKET, BY SETTING, 2021-2028 (USD MILLION)
    • 11.4.8 ASIA PACIFIC: RECESSION IMPACT
  • 11.5 LATIN AMERICA
    • TABLE 162 LATIN AMERICA: PEN NEEDLES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 163 LATIN AMERICA: PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 164 LATIN AMERICA: PEN NEEDLES MARKET, BY LENGTH, 2021-2028 (USD MILLION)
    • TABLE 165 LATIN AMERICA: PEN NEEDLES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 166 LATIN AMERICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021-2028 (USD MILLION)
    • TABLE 167 LATIN AMERICA: PEN NEEDLES MARKET, BY SETTING, 2021-2028 (USD MILLION)
    • 11.5.1 BRAZIL
      • 11.5.1.1 Growing adoption of safety pen needles to drive market
    • TABLE 168 BRAZIL: MACROECONOMIC INDICATORS
    • TABLE 169 BRAZIL: PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 170 BRAZIL: PEN NEEDLES MARKET, BY LENGTH, 2021-2028 (USD MILLION)
    • TABLE 171 BRAZIL: PEN NEEDLES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 172 BRAZIL: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021-2028 (USD MILLION)
    • TABLE 173 BRAZIL: PEN NEEDLES MARKET, BY SETTING, 2021-2028 (USD MILLION)
    • 11.5.2 MEXICO
      • 11.5.2.1 Low coverage for core health services to restrain market
    • TABLE 174 MEXICO: MACROECONOMIC INDICATORS
    • TABLE 175 MEXICO: PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 176 MEXICO: PEN NEEDLES MARKET, BY LENGTH, 2021-2028 (USD MILLION)
    • TABLE 177 MEXICO: PEN NEEDLES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 178 MEXICO: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021-2028 (USD MILLION)
    • TABLE 179 MEXICO: PEN NEEDLES MARKET, BY SETTING, 2021-2028 (USD MILLION)
    • 11.5.3 ARGENTINA
      • 11.5.3.1 High out-of-pocket expenditure on insulin products to restrain market
    • TABLE 180 ARGENTINA: MACROECONOMIC INDICATORS
    • TABLE 181 ARGENTINA: PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 182 ARGENTINA: PEN NEEDLES MARKET, BY LENGTH, 2021-2028 (USD MILLION)
    • TABLE 183 ARGENTINA: PEN NEEDLES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 184 ARGENTINA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021-2028 (USD MILLION)
    • TABLE 185 ARGENTINA: PEN NEEDLES MARKET, BY SETTING, 2021-2028 (USD MILLION)
    • 11.5.4 REST OF LATIN AMERICA
    • FIGURE 46 HEALTH EXPENDITURE OF COUNTRIES IN LATIN AMERICA FOR 2020 (% GDP)
    • TABLE 186 REST OF LATIN AMERICA: PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 187 REST OF LATIN AMERICA: PEN NEEDLES MARKET, BY LENGTH, 2021-2028 (USD MILLION)
    • TABLE 188 REST OF LATIN AMERICA: PEN NEEDLES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 189 REST OF LATIN AMERICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021-2028 (USD MILLION)
    • TABLE 190 REST OF LATIN AMERICA: PEN NEEDLES MARKET, BY SETTING, 2021-2028 (USD MILLION)
    • 11.5.5 LATIN AMERICA: RECESSION IMPACT
  • 11.6 MIDDLE EAST & AFRICA
    • 11.6.1 INITIATIVES TO ENHANCE HEALTHCARE ACCESSIBILITY TO SUPPORT MARKET GROWTH
    • 11.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
    • TABLE 191 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 192 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY LENGTH, 2021-2028 (USD MILLION)
    • TABLE 193 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 194 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021-2028 (USD MILLION)
    • TABLE 195 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY SETTING, 2021-2028 (USD MILLION)

12 COMPETITIVE LANDSCAPE

  • 12.1 OVERVIEW
  • 12.2 KEY PLAYER STRATEGIES
    • TABLE 196 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PEN NEEDLES MARKET
  • 12.3 REVENUE SHARE ANALYSIS
    • FIGURE 47 REVENUE ANALYSIS FOR KEY COMPANIES IN LAST FIVE YEARS
  • 12.4 MARKET SHARE ANALYSIS
    • FIGURE 48 PEN NEEDLES MARKET SHARE, BY KEY PLAYER (2022)
  • 12.5 COMPANY EVALUATION MATRIX (2022)
    • 12.5.1 STARS
    • 12.5.2 EMERGING LEADERS
    • 12.5.3 PERVASIVE PLAYERS
    • 12.5.4 PARTICIPANTS
    • FIGURE 49 PEN NEEDLES MARKET: COMPANY EVALUATION MATRIX (2022)
    • 12.5.5 COMPANY FOOTPRINT
    • TABLE 197 PEN NEEDLES MARKET: OVERALL COMPANY FOOTPRINT (20 COMPANIES)
    • TABLE 198 PEN NEEDLES MARKET: TYPE FOOTPRINT (20 COMPANIES)
    • TABLE 199 PEN NEEDLES MARKET: LENGTH FOOTPRINT (20 COMPANIES)
    • TABLE 200 PEN NEEDLES MARKET: APPLICATION FOOTPRINT (20 COMPANIES)
    • TABLE 201 PEN NEEDLES MARKET: REGIONAL FOOTPRINT (20 COMPANIES)
  • 12.6 START-UP/SME EVALUATION MATRIX (2022)
    • 12.6.1 PROGRESSIVE COMPANIES
    • 12.6.2 RESPONSIVE COMPANIES
    • 12.6.3 DYNAMIC COMPANIES
    • 12.6.4 STARTING BLOCKS
    • FIGURE 50 PEN NEEDLES MARKET: COMPANY EVALUATION MATRIX FOR START-UPS (2022)
    • 12.6.5 COMPETITIVE BENCHMARKING
    • TABLE 202 PEN NEEDLES MARKET: DETAILED LIST OF KEY START-UPS/SMES
  • 12.7 COMPETITIVE SCENARIOS AND TRENDS
    • 12.7.1 PRODUCT LAUNCHES
    • TABLE 203 PEN NEEDLES MARKET: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020-OCTOBER 2023)
    • 12.7.2 DEALS
    • TABLE 204 PEN NEEDLES MARKET: DEALS (JANUARY 2020- OCTOBER 2023)
    • 12.7.3 OTHER DEVELOPMENTS
    • TABLE 205 PEN NEEDLES MARKET: OTHER DEVELOPMENTS (JANUARY 2020- OCTOBER 2023)

13 COMPANY PROFILES

  • (Business overview, Products offered, Recent developments & MnM View)**
  • 13.1 KEY PLAYERS
    • 13.1.1 EMBECTA CORP. (PART OF BD)
    • TABLE 206 EMBECTA CORP.: COMPANY OVERVIEW
    • FIGURE 51 EMBECTA CORP.: COMPANY SNAPSHOT (2022)
    • 13.1.2 NOVO NORDISK A/S
    • TABLE 207 NOVO NORDISK A/S: COMPANY OVERVIEW
    • FIGURE 52 NOVO NORDISK A/S: COMPANY SNAPSHOT (2022)
    • 13.1.3 YPSOMED AG
    • TABLE 208 YPSOMED AG: COMPANY OVERVIEW
    • FIGURE 53 YPSOMED AG: COMPANY SNAPSHOT (2022)
    • 13.1.4 B. BRAUN MELSUNGEN AG
    • TABLE 209 B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW
    • FIGURE 54 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2022)
    • 13.1.5 TERUMO CORPORATION
    • TABLE 210 TERUMO CORPORATION: COMPANY OVERVIEW
    • FIGURE 55 TERUMO CORPORATION: COMPANY SNAPSHOT (2022)
    • 13.1.6 NIPRO CORPORATION
    • TABLE 211 NIPRO CORPORATION: COMPANY OVERVIEW
    • FIGURE 56 NIPRO CORPORATION: COMPANY SNAPSHOT (2022)
    • 13.1.7 OWEN MUMFORD
    • TABLE 212 OWEN MUMFORD: BUSINESS OVERVIEW
    • 13.1.8 ARKRAY, INC.
    • TABLE 213 ARKRAY: BUSINESS OVERVIEW
    • 13.1.9 ULTIMED, INC.
    • TABLE 214 ULTIMED, INC.: BUSINESS OVERVIEW
    • 13.1.10 HINDUSTAN SYRINGES & MEDICAL DEVICES LTD.
    • TABLE 215 HINDUSTAN SYRINGES & MEDICAL DEVICES LTD.: BUSINESS OVERVIEW
    • 13.1.11 MONTMED, INC.
    • TABLE 216 MONTMED, INC.: BUSINESS OVERVIEW
    • 13.1.12 HTL-STREFA
    • TABLE 217 HTL-STREFA: BUSINESS OVERVIEW
    • 13.1.13 ALLISON MEDICAL, INC.
    • TABLE 218 ALLISON MEDICAL, INC.: BUSINESS OVERVIEW
    • 13.1.14 GLUCORX LIMITED
    • TABLE 219 GLUCORX LIMITED: BUSINESS OVERVIEW
    • 13.1.15 BERPU MEDICAL TECHNOLOGY CO., LTD.
    • TABLE 220 BERPU MEDICAL TECHNOLOGY CO., LTD.: BUSINESS OVERVIEW
    • 13.1.16 ADVACARE PHARMA
    • TABLE 221 ADVACARE PHARMA: BUSINESS OVERVIEW
    • 13.1.17 ARTSANA GROUP
    • TABLE 222 ARTSANA GROUP: BUSINESS OVERVIEW
    • 13.1.18 PROMISEMED MEDICAL DEVICES INC.
    • TABLE 223 PROMISEMED MEDICAL DEVICES INC.: BUSINESS OVERVIEW
    • 13.1.19 TRIVIDIA HEALTH, INC.
    • TABLE 224 TRIVIDIA HEALTH, INC.: BUSINESS OVERVIEW
    • 13.1.20 VOGT MEDICAL VERTRIEB GMBH
    • TABLE 225 VOGT MEDICAL VERTRIEB GMBH: BUSINESS OVERVIEW
  • *Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.
  • 13.2 OTHER PLAYERS
    • 13.2.1 VAN HEEK MEDICAL
    • TABLE 226 VAN HEEK MEDICAL: COMPANY OVERVIEW
    • 13.2.2 SIMPLE DIAGNOSTICS
    • TABLE 227 SIMPLE DIAGNOSTICS: COMPANY OVERVIEW
    • 13.2.3 IYON MEDICAL
    • TABLE 228 IYON MEDICAL: COMPANY OVERVIEW
    • 13.2.4 LINKS MEDICAL PRODUCTS, INC.
    • TABLE 229 LINKS MEDICAL PRODUCTS, INC.: COMPANY OVERVIEW
    • 13.2.5 MHC MEDICAL PRODUCTS, LLC
    • TABLE 230 MHC MEDICAL PRODUCTS: COMPANY OVERVIEW

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS